CLINICAL_TRIALS
trial_result
· 2020-02-20
Clinical Trial Update: Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease Patients [Phase 2]
Summary
Phase 2 trial evaluating oral alfacalcidol and its effects on maturation of dendritic cells in Graves' disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dr Cipto Mangunkusumo General Hospital | Conditions: Graves Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-02-20